US and UK diverge over critical COVID-19 vaccine dose strategy

Health authorities in the United Kingdom have recommended extending dosing schedules for approved COVID-19 vaccines, suggesting one dose offers enough short-term protection despite clinical trials only testing two-dose regimes. Authorities in the Unite… Continue reading US and UK diverge over critical COVID-19 vaccine dose strategy

FDA approves first genetically modified pig for food and medical use

The US Food and Drug Administration (FDA) has approved a genetically modified pig for human consumption and therapeutic use. The pig is engineered to be free of a certain sugar molecule responsible for severe allergic reactions in some people.Continue … Continue reading FDA approves first genetically modified pig for food and medical use

Moderna says vaccine prevents severe COVID-19, files for FDA approval

Biotechnology company Moderna has revealed more data from its now-completed Phase 3 COVID-19 vaccine trial. The vaccine is reportedly 94.1 percent effective at preventing COVID-19 and 100 percent effective at preventing severe cases of the disease. An … Continue reading Moderna says vaccine prevents severe COVID-19, files for FDA approval

Pfizer reports COVID-19 vaccine 95% effective as Phase 3 trial concludes

Pfizer and BioNTech have announced their large Phase 3 COVID-19 vaccine trial is complete. The trial has reportedly met all its primary endpoints and the vaccine is claimed to be 95 percent effective.Continue ReadingCategory: Health & Wellbeing, Li… Continue reading Pfizer reports COVID-19 vaccine 95% effective as Phase 3 trial concludes

Experimental drug halves cholesterol levels in phase 2 clinical trials

Scientists are reporting promising results from a phase 2 clinical trial of a cholesterol-reducing drug called evinacumab. The study reports that in patients with extremely high cholesterol, the drug was able to reduce levels by about half, compared to… Continue reading Experimental drug halves cholesterol levels in phase 2 clinical trials

FDA approves prescription-only Apple Watch app for PTSD nightmares

The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of suicide. The U.S. Food and Drug Administration (FDA)… Continue reading FDA approves prescription-only Apple Watch app for PTSD nightmares

FDA approves prescription-only Apple Watch app for PTSD nightmares

The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of suicide. The U.S. Food and Drug Administration (FDA)… Continue reading FDA approves prescription-only Apple Watch app for PTSD nightmares

FDA grants emergency approval to experimental COVID-19 antibody therapy

The U.S. Food and Drug Administration (FDA) has just approved the first coronavirus-specific antibody treatment for moderate cases of COVID-19. The focused Emergency Use Authorization (EUA) is aimed at newly diagnosed infections at the highest risk of … Continue reading FDA grants emergency approval to experimental COVID-19 antibody therapy

Experimental ALS drug prolongs survival in Phase 2 human trial

The ALS Association is petitioning the FDA to forego Phase 3 trial requirements so the new drug can be put on the market immediately

An experimental drug treating amyotrophic lateral sclerosis (ALS) is demonstrating promising potential, both slowing the progression of this neurodegenerative disease and prolonging patient survival. Phase 2 human trials are complete and Amylyx Pharmaceuticals, the company developing the treatment, says it is working with regulatory bodies on the steps necessary to bring the drug to market ahead of a Phase 3 trial.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , ,

Continue reading Experimental ALS drug prolongs survival in Phase 2 human trial

Experimental molecule may reduce side effects of controversial diabetes drug

A newly developed experimental drug could help mitigate some of the dangerous side effects caused by a once-promising diabetes medication. Early animal tests suggest the novel combination treatment is both safe and effective at helping regulate blood s… Continue reading Experimental molecule may reduce side effects of controversial diabetes drug